Wendelin Maners
About Wendelin Maners
Wendelin Maners serves as the President and CEO of CSA Medical Inc, a position he has held since 2019. He has a background in business development and strategy, having previously worked at Boston Scientific and played a significant role in medical device therapy advancements.
Work at CSA Medical
Wendelin Maners has served as President and CEO of CSA Medical Inc since 2019. In this role, he oversees the company's strategic direction and operations from their headquarters in Lexington, MA. Under his leadership, CSA Medical has advanced its pivotal study for a breakthrough therapy, currently enrolling at 25 sites across the U.S. and U.K. Previously, he held multiple positions within the company, including Vice President of Emerging Therapies and Chief Commercial Officer. His tenure at CSA Medical reflects a commitment to innovation in medical device therapies.
Previous Experience at Boston Scientific
Before joining CSA Medical, Wendelin Maners worked at Boston Scientific from 2003 to 2011 as Vice President of Business Development and Strategy. During his eight years at the company, he played a significant role in shaping business strategies and developing new opportunities within the medical device sector. His experience at Boston Scientific provided a strong foundation for his subsequent leadership roles in the medical technology industry.
Medical Device Innovations
Wendelin Maners has been instrumental in the development and implementation of innovative medical device therapies. Notably, he contributed to a novel therapy for Chronic Obstructive Pulmonary Disease (COPD) with Chronic Bronchitis, which utilizes a liquid nitrogen 'metered cryospray'. This advancement reflects his focus on improving patient outcomes through cutting-edge technology in the medical field.
Education and Expertise
Wendelin Maners studied Finance at the USC Marshall School of Business from 1983 to 1985. His educational background in finance has equipped him with the skills necessary for effective leadership in the business aspects of the medical technology industry. This expertise supports his roles in strategic planning and business development throughout his career.
Regulatory Achievements
Under Wendelin Maners' leadership, CSA Medical achieved CE Mark approval for its specialty cryotherapy devices in the European Union. This regulatory milestone demonstrates the company's commitment to meeting international standards for medical devices and reflects the effectiveness of its innovative therapies in the market.